Login

From the Helm: Lindsay Partridge on Brickworks' Growth and Dividend Success | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Future of Investment DAOs |Vic Singh,Co-Founder,Eniac Ventures
00:10:00
Hecla Mining CEO Phillips J. Baker discusses the acquisition of Alexco Resource Corp. and its Keno Hill mine, highlighting growth potential in the Yukon and expansion plans into Latin America, emphasizing silver's importance in renewable energy technologi
00:10:00
Exploring Breakthroughs: Insights into Mitochondrial Disease Treatments and Clinical Trials | Ellen Wittmack Donnelly, CEO, Abliva AB.
00:10:00
Driving Total Shareholder Returns: Navigating the Mining Sector's Role in the Energy Transition and ESG Imperatives|Olivia Markham,Portfolio Manager, BlackRock2
00:00:00
Mike Lampron – CEO - Mach7 Technologies
00:10:00
Private Equity Perspectives: Insights from Sachin Khajuria | Sachin Khajuria - Founder, Achilles Management
00:10:00
Ironspring Ventures is a sector-focused venture capital fund investing in digital industrial innovation|Peter Holt,Co-Founder and General Partner,Ironspring Ventures
00:10:00
Exploring AI in Financial Institutions: Benefits and Perspectives
00:10:00
Backed by some of the most famous people on the internet|Ezra Cooperstein,General Partner,Night Ventures
00:10:00
CEO Rosario Pingaro Unveils Convergenze’s Story, Values, and Ambitious Fiber Optic Project in Sapri | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Mitigating Natural Gas Price Challenges: Perspectives from Latvian Energy Leader | Aigars Kalvītis, CEO, AS Latvijas Gaze.
00:10:00
Insights from Stephen Ambrosini of 20/20 Financial Advisers

© 2017 - Neuhu+